NCT03047954View on ClinicalTrials.gov

Broncho-Vaxom (OM 85 BV) in Children Suffering From Atopic Dermatitis

PHASE3CompletedINTERVENTIONAL
Enrollment

179

Participants

Timeline

Start Date

July 31, 2003

Primary Completion Date

December 31, 2006

Study Completion Date

December 31, 2006

Conditions
Atopic Dermatitis
Interventions
DRUG

Broncho-Vaxom

BV is an orally administered immunostimulating preparation, which consists of a lyophilised bacterial extract prepared from 8 bacterial species (Haemophilus influenzae, Streptococcus pneumoniae, Klebsiella pneumoniae and ozaenae, Staphylococcus aureus, Streptococcus pyogenes and viridans, Neisseria catarrhalis)

DRUG

Placebo - Cap

Matching Placebo capsule administered

Sponsors

Lead Sponsor

Vifor Pharma
All Listed Sponsors
lead

Vifor Pharma

INDUSTRY